Jessica’s research interests include the design of novel CAR-T therapy approaches in the lung using novel intracellular checkpoint blockade targets (CASS Foundation Medicine/Science grant) as well as investigating the signalling pathways of unconventional T cells and their contribution to inflammation in models of pulmonary disease. In 2019, she became a lecturer and course co-ordinator of graduate studies, establishing a Master's course in Translational Research and Medicine at the Central Clinical School. Dr Borger was awarded a Veski Inspiring women STEM side-by-side scholarship for mid-career emerging leaders, nominated for The Times 100 Women of Influence Award 2019 and was the inaugural recipient of the Margaret Baird Women in Immunology Award from the Australia and New Zealand Society of Immunology (2019).Read more about Jessica Borger's research
Jessica Borger's Articles
The discovery disconnect
The economic and social consequences of the COVID-19 crisis have reinforced gender inequality across the globe – as shown in the medical research field.